October 08, 2012

Sanofi Announces Final Results of its Modified Dutch Auction Tender Offer for its Outstanding Contingent Value Rights

 

Sanofi Announces Final Results of its Modified Dutch Auction Tender Offer for its Outstanding Contingent Value Rights

Paris, France – October 8, 2012 – Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that it has accepted to purchase all CVRs properly tendered, representing a total of 40,025,805 CVRs, for a total cost of approximately US $70 million, excluding fees and expenses related to the tender offer. According to American Stock Transfer & Trust Company, LLC, the depositary for the tender offer, 40,025,805 CVRs were properly tendered at or below the final purchase price of $1.75 per CVR and not properly withdrawn.